Olga Gurgula

Brunel University London - Brunel Law School

Kingston Lane

Elliott Jaques Building

Uxbridge, Middlesex UB8 3PH

United Kingdom

SCHOLARLY PAPERS

30

DOWNLOADS
Rank 12,214

SSRN RANKINGS

Top 12,214

in Total Papers Downloads

7,458

SSRN CITATIONS
Rank 36,853

SSRN RANKINGS

Top 36,853

in Total Papers Citations

25

CROSSREF CITATIONS

2

Scholarly Papers (30)

1.

Patent Strategies and Competition Law in the Pharmaceutical Sector: Implications for Access to Medicines

European Intellectual Property Review, Forthcoming, Queen Mary School of Law Legal Studies Research Paper No. 233/2016
Number of pages: 13 Posted: 13 May 2016 Last Revised: 15 Nov 2016
Duncan Matthews and Olga Gurgula
Queen Mary University of London - School of Law and Brunel University London - Brunel Law School
Downloads 1,357 (27,836)
Citation 2

Abstract:

Loading...

competition law,access to medicines,reverse payment agreements,strategic patenting,pharmaceutical industry, patents, abuse of intellectual property,patent thickets,evergreening,product switching,defensive patenting

2.

Compulsory Licensing vs. the IP Waiver: What Is the Best Way to End the COVID-19 Pandemic?

Policy brief 104, October 2021, the South Centre
Number of pages: 13 Posted: 01 Nov 2021 Last Revised: 03 Nov 2021
Olga Gurgula
Brunel University London - Brunel Law School
Downloads 896 (50,342)
Citation 7

Abstract:

Loading...

compulsory licensing, the WTO IP waiver, EU proposal on compulsory licensing, COVID-19 vaccines, patents, trade secrets

3.

Compulsory Licensing of Trade Secrets: Ensuring Access to COVID-19 Vaccines via Involuntary Technology Transfer

Queen Mary Law Research Paper No. 363/2021, Journal of Intellectual Property Law & Practice, Volume 18, Issue 6, June 2023, Pages 418–431
Number of pages: 29 Posted: 28 Jun 2021 Last Revised: 19 Jul 2023
Olga Gurgula and John Hull
Brunel University London - Brunel Law School and Centre for Commercial Legal Studies
Downloads 834 (55,547)
Citation 2

Abstract:

Loading...

COVID-19 vaccines, compulsory licensing, IP waiver, TRIPS, patents, trade secrets, technology transfer

4.

Drug Prices, Patents and Access to Life-Saving Medicines: Changes Are Urgently Needed in the COVID-19 Era

Forthcoming in the European Intellectual Property Review (EIPR)
Number of pages: 11 Posted: 08 Feb 2021 Last Revised: 05 May 2021
Olga Gurgula
Brunel University London - Brunel Law School
Downloads 654 (76,399)
Citation 2

Abstract:

Loading...

patents, strategic patenting, access to medicines, high drug prices, COVID-19

5.

AI-Assisted Inventions in the Field of Drug Discovery: Readjusting the Inventive Step Analysis

International Journal of Social Science and Public Policy, Vol. 2, No. 8; August 2020
Number of pages: 29 Posted: 21 Sep 2020 Last Revised: 05 Jul 2023
Olga Gurgula
Brunel University London - Brunel Law School
Downloads 489 (109,638)

Abstract:

Loading...

artificial intelligence, inventive step, obviousness, patents, drug discovery, access to medicines

6.

Strategic Patenting by Pharmaceutical Companies: Should Competition Law Intervene?

IIC - International Review of Intellectual Property and Competition Law, Volume 51, pages 1062–1085 (2020)
Number of pages: 26 Posted: 28 Aug 2020 Last Revised: 01 Nov 2021
Olga Gurgula
Brunel University London - Brunel Law School
Downloads 359 (156,500)
Citation 2

Abstract:

Loading...

strategic patenting, evergreening, pharmaceutical patents, anticompetitive, generic competition, access to medicines, access to COVID-19 treatment

7.

On the European Commission’s Proposal to Create a New EU-wide Compulsory Licensing Regime

Forthcoming in the European Intellectual Property Review (EIPR)
Number of pages: 15 Posted: 14 Sep 2023 Last Revised: 29 Nov 2023
Olga Gurgula
Brunel University London - Brunel Law School
Downloads 238 (239,247)

Abstract:

Loading...

Compulsory licensing, the European Commission’s proposal, access to medicines, emergency, crisis, EU, patents, access to confidential information, trade secrets, pharmaceutical industry

8.

Strategic Accumulation of Patents in the Pharmaceutical Industry and Patent Thickets in Complex Technologies — Two Different Concepts Sharing Similar Features

IIC - International Review of Intellectual Property and Competition Law, volume 48, pages 385–404 (2017), Queen Mary School of Law Legal Studies Research Paper No. 242/2016
Number of pages: 20 Posted: 14 Oct 2016 Last Revised: 05 Jul 2023
Olga Gurgula
Brunel University London - Brunel Law School
Downloads 217 (261,126)
Citation 4

Abstract:

Loading...

Patent Thickets, Strategic Accumulation of Patents, Perindopril, Anticompetitive Practices, The Pharmaceutical Industry, Patent Wars

9.

Saving Ukrainian Lives during the Russian War: Ukraine Must Waive IP Rights under Article 73 TRIPS to Provide Access to Essential Medicines

GRUR International, Volume 71, Issue 8, August 2022, pages 719–730
Number of pages: 24 Posted: 19 Apr 2022 Last Revised: 05 Jul 2023
Olga Gurgula
Brunel University London - Brunel Law School
Downloads 216 (262,312)
Citation 1

Abstract:

Loading...

russian war against Ukraine, IP rights, access to medicines, compulsory licensing, IP waiver, patents, Article 73 TRIPS, security exceptions

10.

Access Denied: the Role of Trade Secrets in Preventing Global Equitable Access to COVID-19 Tools

STOPAIDS & JUST TREATMENT, MARCH 2023
Number of pages: 46 Posted: 19 Jun 2023
Olga Gurgula and Luke McDonagh
Brunel University London - Brunel Law School and LSE Law
Downloads 204 (276,488)

Abstract:

Loading...

Trade secrets, COVISD-19, UK Government, pharmaceutical companies, access to medicines, transparency, technology transfer, compulsory licensing, fair distribution of IP ownership, competition and open innovation

11.

COVID-19, IP and Access: Will the Current System of Medical Innovation and Access to Medicines Meet Global Expectations?

Forthcoming in the Journal of Generic Medicines
Number of pages: 12 Posted: 26 Jan 2021
Olga Gurgula and Wen Hwa Lee
Brunel University London - Brunel Law School and University of Oxford - Oxford Martin School
Downloads 202 (278,986)
Citation 1

Abstract:

Loading...

COVID-19, patents, access to medicines, affordable medicines, compulsory licensing, open innovation

12.

Restrictive Practices in the Pharmaceutical Industry: Reverse Payment Agreements Seeking for a Balance between Intellectual Property and Competition Law

This article was published in the ICC Global Antitrust Review Issue 5, 2012
Number of pages: 32 Posted: 25 Sep 2016
Olga Gurgula
Brunel University London - Brunel Law School
Downloads 197 (285,403)
Citation 2

Abstract:

Loading...

Reverse payment agreements, patents, pharmaceutical industry, drugs

13.

Anticompetitive Patent Acquisitions in the Pharmaceutical Industry

European Competition Law Review, vol. 38, Issue 1 (2017).
Number of pages: 7 Posted: 13 Nov 2016 Last Revised: 07 Feb 2018
Olga Gurgula
Brunel University London - Brunel Law School
Downloads 188 (297,578)

Abstract:

Loading...

pharmaceutical patents, patent acquisitions, Perindopril, Bioval, anticompetitive behaviour, monopolisation, abuse of dominant position

14.

Accelerating COVID-19 Vaccine Production via Involuntary Technology Transfer

The South Centre policy brief 102 (September 2021)
Number of pages: 9 Posted: 20 Sep 2021 Last Revised: 27 Sep 2021
Olga Gurgula
Brunel University London - Brunel Law School
Downloads 175 (317,190)
Citation 3

Abstract:

Loading...

COVID-19 vaccine technologies, trade secrets, patents, the TRIPS IP waiver, compulsory licensing, technology transfer

15.

Monopoly v. Openness: Two Sides of IP Coin in the Pharmaceutical Industry

Forthcoming, Journal of World Intellectual Property
Number of pages: 16 Posted: 24 Jun 2017 Last Revised: 01 May 2019
Olga Gurgula
Brunel University London - Brunel Law School
Downloads 166 (331,937)

Abstract:

Loading...

patents; the pharmaceutical industry; access to medicines; open innovation

16.

Patenting Strategies by Pharmaceutical Companies: A Lawful Use of the Patent System or an Abusive Conduct?

Book chapter in Bonadio and Shemtov (ed), ‘A Research Agenda for Patent Law’, Edward Elgar, Forthcoming
Number of pages: 24 Posted: 08 Nov 2023 Last Revised: 06 Feb 2024
Olga Gurgula
Brunel University London - Brunel Law School
Downloads 116 (440,787)

Abstract:

Loading...

Patent strategies, anticompetitive practices, generic competition, competition law, patent law, European commission, strategic patenting, strategic accumulation of patents, product hopping, Perindopril, AstraZeneca, Humira, Prozac, access to medicines

17.

Affordable Medicines and Innovation: Consequences and Lessons from Countries with Different Patentability Standards

Bio-Science Law Review, forthcoming
Number of pages: 14 Posted: 18 Nov 2021 Last Revised: 22 Nov 2021
University of Cambridge, Brunel University London - Brunel Law School, affiliation not provided to SSRN, affiliation not provided to SSRN and University of Oxford - Oxford Martin School
Downloads 115 (443,659)

Abstract:

Loading...

patents, access to medicines, TRIPS, strong patent protection, open innovation

18.

The new IP Court in Ukraine: Its Creation and Exclusive Jurisdiction

Book chapter in Richter (ed), Competition and Intellectual Property in Ukraine, Springer, Forthcoming 2022
Number of pages: 18 Posted: 08 Feb 2022
Anna Shtefan and Olga Gurgula
Intellectual Property Scientific Research Institute of the National Academy of Legal Sciences of Ukraine and Brunel University London - Brunel Law School
Downloads 105 (474,197)
Citation 1

Abstract:

Loading...

IP court, IP litigation, IP judiciary, IP disputes, exclusive jurisdiction, Ukrainian judicial reform

19.

Ukraine DFID/FCO IP Court Project: The Final Report

Queen Mary Law Research Paper No. 353/2021, Bocconi Legal Studies Research Paper No. 3789913
Number of pages: 209 Posted: 22 Feb 2021
Queen Mary University of London, Centre for Commercial Law Studies, Brunel University London - Brunel Law School, Queen Mary University of London, University College London and Intellectual Property Scientific Research Institute of the National Academy of Legal Sciences of Ukraine
Downloads 98 (497,090)

Abstract:

Loading...

specialised IP Court, Ukraine, IP enforcement, IP adjudication, IP judiciary, IP disputes

20.

Ліки та Патенти: Міфи, Реальність, Конкуренція Та Міжнародна Практика (Drugs and Patents: Myths, Realities, Competition and International Practice)

Ця стаття надрукована в Юридичній Газеті від 7.02.2017 N 6(556), Legal Journal (Yuridichna Gazeta) 7.02.2017 N 6(556))
Number of pages: 7 Posted: 12 Feb 2017 Last Revised: 14 Mar 2017
Olga Gurgula
Brunel University London - Brunel Law School
Downloads 91 (521,271)

Abstract:

Loading...

Патент, фармацевтична галузь, ліки, конкуренція, антимонопольний, антиконкуренційні дії, зловживання монопольним становищем

21.

Invoking Article 73 TRIPS in Good Faith: No Recourse to ‘Security Exceptions’ for Russia’s Violation of Trips

Published in Journal of Intellectual Property Law & Practice (Oxford) on 06 April 2023
Number of pages: 21 Posted: 09 Nov 2022 Last Revised: 10 May 2023
Olga Gurgula
Brunel University London - Brunel Law School
Downloads 77 (576,537)

Abstract:

Loading...

Russia’s war against Ukraine, TRIPS, WTO dispute settlement, compulsory licensing, IP waiver, Article 73 TRIPS, security exceptions, good faith, violation of TRIPS, national treatment, most-favoured-nation

22.

Anticompetitive Patent Strategies by Pharmaceutical Companies

This paper was presented at the International Scientific and Practical Conference ‘Second Scientific Readings in Memory of Professor G. V. Pronska’ held on 21 April 2023
Number of pages: 5 Posted: 04 May 2023
Olga Gurgula
Brunel University London - Brunel Law School
Downloads 76 (580,944)

Abstract:

Loading...

Pharmaceutical competition, medicines, high drug prices, patent strategies, strategic patenting, strategic accumulation of patents, anticompetitive patent strategies, pay-for-delay agreements, divisional patent applications, the European Commission, the Antimonopoly Committee of Ukraine

23.

The ‘Obvious to Try’ Method of Addressing Strategic Patenting: How Developing Countries Can Utilise Patent Law to Facilitate Access to Medicines

South Centre, Policy Brief 59, April 2019
Number of pages: 12 Posted: 30 May 2019
Olga Gurgula
Brunel University London - Brunel Law School
Downloads 66 (627,003)
Citation 2

Abstract:

Loading...

Strategic patenting, pharmaceutical patents, evergreening, secondary patenting, pharmaceutical industry, access to medicines, developing counties

24.

Specialised IP Judiciary: What Are the Key Elements to Consider when Establishing or Reforming an Effective IP Court?

GRUR International, Volume 71, Issue 3, March 2022, pages 206–212, Queen Mary Law Research Paper No. 371/2021
Number of pages: 16 Posted: 24 Nov 2021 Last Revised: 05 Jul 2023
Olga Gurgula, Maciej Padamczyk and Noam Shemtov
Brunel University London - Brunel Law School, Queen Mary University of London and Queen Mary University of London, Centre for Commercial Law Studies
Downloads 63 (642,127)

Abstract:

Loading...

IP disputes, specialised IP courts, IP adjudication, IP litigation, intellectual property

25.

The Intersection Between Intellectual Property and Competition Laws in the Pharmaceutical Sector: A Ukrainian Perspective

Book chapter in Richter (ed), Competition and Intellectual Property in Ukraine, Springer, 2022 Forthcoming
Number of pages: 26 Posted: 11 May 2022
Olga Gurgula
Brunel University London - Brunel Law School
Downloads 57 (674,242)

Abstract:

Loading...

Ukraine, access to medicines, competition law, pay-for-delay agreements, anticompetitive strategies, anticompetitive agreements, intellectual property, patents

26.

US Supreme Court Decision on Reverse Payment Agreements: New Era in Patent Litigation Settlements – FTC v. Actavis, Inc., 570 US (2013)

Published in Queen Mary Journal of Intellectual Property, Vol. 3 No. 4, pp. 325-335, 2013
Number of pages: 10 Posted: 29 Sep 2016 Last Revised: 02 Oct 2016
Olga Gurgula
Brunel University London - Brunel Law School
Downloads 57 (674,242)

Abstract:

Loading...

Actavis, antitrust, drugs, patents, pharmaceutical, reverse payment agreements

27.

Обмеження прав інтелектуальної власності під час війни для забезпечення доступу до критично необхідних ліків в Україні на підставі статті 73 ТРІПС (Implementing the IP Waiver during the War to Enhance Access to Essential Medicines in Ukraine under Article 73 TRIPS)

Тези доповіді для Міжнародного круглого столу 'Правові питання епідемічної безпеки під час воєнного стану' (16 червня 2022 року) (Conference Paper for the International Roundtable 'Legal Aspects of Epidemiologic Safety during Martial Law')
Number of pages: 4 Posted: 21 Jun 2022
Olga Gurgula
Brunel University London - Brunel Law School
Downloads 55 (685,520)

Abstract:

Loading...

Російська війна проти України, права інтелектуальної власності, доступ до ліків, обмеження прав інтелектуальної власності, патенти, Статті 73 ТРІПС, винятки щодо безпеки, Russian war against Ukraine, IP rights, access to medicines, IP waiver, patents, Article 73 TRIPS, security exceptions

28.

The Bolar exemption and patent linkage in Ukraine

Number of pages: 24 Posted: 28 Mar 2024
Olga Gurgula
Brunel University London - Brunel Law School
Downloads 42 (768,803)

Abstract:

Loading...

the Bolar exemption, patent linkage, Ukraine, access to medicines, generic competition, harmonisation of the Bolar exemption in the EU, patent abuse

29.

On Compulsory Licensing of Trade Secrets

Number of pages: 35 Posted: 28 Mar 2024
Olga Gurgula and Luke McDonagh
Brunel University London - Brunel Law School and LSE Law
Downloads 34 (829,451)

Abstract:

Loading...

Compulsory licensing, trade secrets, patents, Crown use, involuntary (compelled) technology transfer, access to medicines, freedom of information (FOI) request, the UK MHRA, UK legislative reform, pandemic preparedness

30.

Proposal for a new Article 11bis in the WHO Pandemic Accord: a Pandemic Technology Transfer Mechanism

SOUTHVIEWS NO. 261, 23 APRIL 2024 (The South Centre)
Number of pages: 7 Posted: 25 Apr 2024
Olga Gurgula and Luke McDonagh
Brunel University London - Brunel Law School and LSE Law
Downloads 14 (1,019,091)

Abstract:

Loading...

Access to Medical Technologies, Access to Medicines, Access to Vaccines, Article 11bis, Compulsory Licenses, COVID-19, Global Health, Health, Health Emergencies, Intellectual Property, Intergovernmental Negotiating Body (INB), Pandemic, Pandemic Accord, Pandemic Instrument, Pandemic Preparedness